Abe Frederick Clark, PhD

Abe Clark, PhD

Exec Director and Professor - Pharmacology & Neuroscience
Pharmacology & Neuroscience
Research interests:Glaucoma research with special focus on trabecular meshwork, optic nerve head, and retinal ganglion cells

Dr. Abe Clark is known for innovative research that primarily focuses on understanding the biochemical, cellular and molecular mechanisms involved in the pathobiology of glaucoma and other ocular diseases. He collaborates with laboratories throughout the U.S., as well as internationally.

After serving as a research scientist and Vice President of Discovery Research and head of Glaucoma Research for Alcon Laboratories, Inc., Dr. Clark retired and joined UNTHSC as professor in 2008. While at Alcon, he also served UNTHSC for more than 20 years as an adjunct professor in the departments of Cell Biology & Genetics and Pharmacology & Neuroscience.

Dr. Clark and fellow collaborators have discovered glaucoma-associated genes and glaucomatous pathogenic pathways using molecular genetics, differential gene expression, proteomics, ocular cell culture, ex vivo organ culture, and rodent models of glaucoma.

He has published 185 peer-reviewed manuscripts, 280 abstracts, authored 15 book chapters and two books, given 103 invited seminars nationally and internationally, and is an inventor with more than 70 patents.

Dr. Clark serves as graduate adviser for the Visual Sciences Program.
Academic:Doctor of Philosophy, Microbiology, Case Western Reserve University

Bachelor of Arts, Biology, Thiel College

Honors:Recipient, UNTHSC President’s Awards for Education and Research Excellence (2012, 2013)

Graduate Student Association Outstanding Faculty Award (2011, 2014)

Recipient, World Glaucoma Association Prize for Glaucoma Research (2008)

Fellow, The Association for Research in Vision and Ophthalmology

Editorial Boards: Experimental Eye Research, Molecular Neurodegeneration, J. Ocular Pharmacology & Therapeutics, Molecular Vision